Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Free Cash Flow (2016 - 2026)

Ekso Bionics Holdings has reported Free Cash Flow over the past 14 years, most recently at -$4.5 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow fell 206.53% to -$4.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$12.0 million, a 21.31% decrease, with the full-year FY2025 number at -$12.0 million, down 21.31% from a year prior.
  • Free Cash Flow reached -$4.5 million in Q4 2025 per EKSO's latest filing, down from -$2.1 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$1.5 million in Q4 2024, with the low at -$4.5 million in Q4 2025.
  • The 5-year median for Free Cash Flow is -$3.0 million (2021), against an average of -$3.0 million.
  • Peak YoY movement for Free Cash Flow: soared 55.99% in 2023, then plummeted 206.53% in 2025.
  • Tracing EKSO's Free Cash Flow over 5 years: stood at -$3.1 million in 2021, then fell by 20.27% to -$3.7 million in 2022, then soared by 55.99% to -$1.6 million in 2023, then grew by 10.63% to -$1.5 million in 2024, then plummeted by 206.53% to -$4.5 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$4.5 million, -$2.1 million, and -$3.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.